ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
+24.94%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$55.8M
AUM Growth
+$55.8M
(+20%)
Cap. Flow
+$4.47M
Cap. Flow
% of AUM
8.01%
Top 10 Holdings %
Top 10 Hldgs %
49.65%
Holding
44
New
22
Increased
4
Reduced
7
Closed
11
Top Buys
| 1 |
Baxter International
BAX
|
$4.36M |
| 2 |
Centene
CNC
|
$2.79M |
| 3 |
Guardant Health
GH
|
$2.75M |
| 4 |
Viatris
VTRS
|
$2.67M |
| 5 |
UnitedHealth
UNH
|
$1.89M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$3.64M |
| 2 |
Insmed
INSM
|
$3.26M |
| 3 |
PTC Therapeutics
PTCT
|
$3.12M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$2.73M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$2.41M |
Sector Composition
| 1 | Healthcare | 83.32% |
| 2 | Financials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Baxter International
BAX
$12.7B
| $4.36M | 7.82% | +52,192 | New | +$4.36M |
|
2
BioMarin Pharmaceuticals
BMRN
$11.2B
| $2.86M | 5.12% | 33,781 -15,481 | -31% | -$1.31M |
|
|
3
Centene
CNC
$14.3B
| $2.79M | 5.01% | +44,426 | New | +$2.79M |
|
|
4
Guardant Health
GH
$8.41B
| $2.75M | 4.93% | +35,236 | New | +$2.75M |
|
|
5
Insmed
INSM
$28.8B
| $2.72M | 4.87% | 113,875 -136,709 | -55% | -$3.26M |
|
|
6
Viatris
VTRS
$12.3B
| $2.67M | 4.79% | +132,855 | New | +$2.67M |
|
|
7
PTC Therapeutics
PTCT
$3.92B
| $2.66M | 4.77% | 55,408 -65,041 | -54% | -$3.12M |
|
8
Tandem Diabetes Care
TNDM
$845M
| $2.6M | 4.65% | 43,559 +24,564 | +129% | +$1.46M |
|
9
Bio-Rad Laboratories Class A
BIO
$8.06B
| $2.35M | 4.21% | 6,351 +713 | +13% | +$264K |
|
|
ARNA
10
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.94M | 3.48% | 42,688 +26,416 | +162% | +$1.2M |
|
|
11
UnitedHealth
UNH
$281B
| $1.89M | 3.38% | +6,414 | New | +$1.89M |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.72M | 3.08% | +4,584 | New | +$1.72M |
|
|
MYOK
13
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.68M | 3.01% | 23,023 -24,879 | -52% | -$1.81M |
|
14
AbbVie
ABBV
$372B
| $1.68M | 3% | +18,921 | New | +$1.68M |
|
|
AERI
15
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.51M | 2.71% | +62,507 | New | +$1.51M |
|
|
DERM
16
DELISTED
Dermira, Inc.
DERM
| $1.44M | 2.58% | +81,127 | New | +$1.44M |
|
17
Exicure
XCUR
$35.4M
| $1.43M | 2.56% | +500,000 | New | +$1.43M |
|
18
Esperion Therapeutics
ESPR
$448M
| $1.36M | 2.44% | +22,872 | New | +$1.36M |
|
19
Gilead Sciences
GILD
$140B
| $1.35M | 2.42% | 20,791 -32,695 | -61% | -$2.12M |
|
|
BMY.RT
20
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $1.25M | 2.24% | +415,931 | New | +$1.25M |
|
|
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.24M | 2.21% | +62,585 | New | +$1.24M |
|
22
eHealth
EHTH
$118M
| $1.23M | 2.2% | +15,004 | New | +$1.23M |
|
|
PTLA
23
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.18M | 2.12% | 49,431 -100,868 | -67% | -$2.41M |
|
24
Twist Bioscience
TWST
$1.63B
| $1.14M | 2.05% | 54,334 +16,116 | +42% | +$338K |
|
|
VRAY
25
DELISTED
ViewRay, Inc.
VRAY
| $1.08M | 1.94% | +256,205 | New | +$1.08M |
|